AU Patent

AU2010315361B2 — Quinazoline compounds

Assigned to GlaxoSmithKline LLC · Expires 2014-06-12 · 12y expired

What this patent protects

Disclosed are compounds having the formula: wherein R

USPTO Abstract

Disclosed are compounds having the formula: wherein R

Drugs covered by this patent

Inrebic (FEDRATINIB HYDROCHLORIDE) · Bristol-Myers Squibb

Patent Metadata

Patent number: AU2010315361B2
Jurisdiction: AU
Classification: —
Expires: 2014-06-12
Drug substance claim: No
Drug product claim: No
Assignee: GlaxoSmithKline LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.